Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Roy

Showing results (461-470 of 462) with videos related to

Pageof 47
Sort By:
You have reached the last page of results.This site can display upto 462 results.
Nature Communications|December 20, 2024
Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathwaysNaziia Kurmasheva, Aida Said, Boaz Wong, et al.
Nature Communications|May 15, 2024
Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathwaysNaziia Kurmasheva, Aida Said, Boaz Wong, et al.
Pageof 47

Showing results (461-470 of 462) with videos related to

Sort By:
Pageof 47
You have reached the last page of results.This site can display upto 462 results.
Nature Communications|December 20, 2024
Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathwaysNaziia Kurmasheva, Aida Said, Boaz Wong, et al.
Nature Communications|May 15, 2024
Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathwaysNaziia Kurmasheva, Aida Said, Boaz Wong, et al.
Pageof 47